icon-    folder.gif   Conference Reports for NATAP  
 
  IAS 2015: 8th IAS Conference on
HIV Pathogenesis Treatment and Prevention
Vancouver, Canada
18-22 July 2015
Back grey_arrow_rt.gif
 
 
 
Bioequivalence of Two Dosage Strength Fixed-Dose Combination Formulations of Emtricitabine/Tenofovir Alafenamide (F/TAF) to Elvitegravir/Cobicistat/Emtricitabine/TAF (E/C/F/TAF)
 
 
  Reported by Jules Levin
8th IAS Conference on HIV Pathogenesis,
Treatment, and Prevention
Vancouver, British Columbia, Canada
19-22 July 2015
 
J Zack, S West, M Rhee, R Yu, A Vu, BP Kearney
Gilead Sciences, Foster City, California, USA
 
Pharmacokinetics of a Novel EVG/COBI/FTC/GS-7340 Single Tablet

Regimen.....http://www.natap.org/2012/pharm/Pharm_24.htm
13th HIV Clinical Pharmacology Workshop Apr 16-18 2012 Barcelona Spain
 
This study compares TAF 25 to TDF PK
http://www.natap.org/2015/EACS/EACS_57.htm

HIV1

HIV2

HIV3

HIV4

HIV5

HIV6

HIV7

HIV8

HIV9

HIV10